143 related articles for article (PubMed ID: 33404636)
1. Mortality in SLE patients compared with population controls in Finland in years 2000-2015.
Elfving P; Kariniemi S; Kautiainen H; Virta LJ; Kaipiainen-Seppänen O; Puolakka K
Rheumatology (Oxford); 2021 Sep; 60(9):4238-4244. PubMed ID: 33404636
[TBL] [Abstract][Full Text] [Related]
2. Mortality and causes of death among incident cases of systemic lupus erythematosus in Finland 2000-2008.
Elfving P; Puolakka K; Kautiainen H; Virta LJ; Pohjolainen T; Kaipiainen-Seppänen O
Lupus; 2014 Nov; 23(13):1430-4. PubMed ID: 25057036
[TBL] [Abstract][Full Text] [Related]
3. Good survival rates in systemic lupus erythematosus in southern Sweden, while the mortality rate remains increased compared with the population.
Ingvarsson RF; Landgren AJ; Bengtsson AA; Jönsen A
Lupus; 2019 Oct; 28(12):1488-1494. PubMed ID: 31551031
[TBL] [Abstract][Full Text] [Related]
4. Mortality and cardiovascular burden of systemic lupus erythematosus in a US population-based cohort.
Bartels CM; Buhr KA; Goldberg JW; Bell CL; Visekruna M; Nekkanti S; Greenlee RT
J Rheumatol; 2014 Apr; 41(4):680-7. PubMed ID: 24532834
[TBL] [Abstract][Full Text] [Related]
5. Multimorbidity among incident Finnish systemic lupus erythematosus patients during 2000-2017.
Kariniemi S; Rantalaiho V; Virta LJ; Puolakka K; Sokka-Isler T; Elfving P
Lupus; 2021 Jan; 30(1):165-171. PubMed ID: 33086917
[TBL] [Abstract][Full Text] [Related]
6. Initial disease severity, cardiovascular events and all-cause mortality among patients with systemic lupus erythematosus.
Li D; Yoshida K; Feldman CH; Speyer C; Barbhaiya M; Guan H; Solomon DH; Everett BM; Costenbader KH
Rheumatology (Oxford); 2020 Mar; 59(3):495-504. PubMed ID: 31321417
[TBL] [Abstract][Full Text] [Related]
7. Impact of early systemic lupus erythematosus on work disability-results from the Finnish nationwide register 2000-2007.
Elfving P; Puolakka K; Rantalaiho V; Kautiainen H; Virta LJ; Kaipiainen-Seppänen O
Clin Rheumatol; 2018 May; 37(5):1413-1416. PubMed ID: 29541950
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous lupus erythematosus and systemic lupus erythematosus are associated with clinically significant cardiovascular risk: a Danish nationwide cohort study.
Hesselvig JH; Ahlehoff O; Dreyer L; Gislason G; Kofoed K
Lupus; 2017 Jan; 26(1):48-53. PubMed ID: 27235406
[TBL] [Abstract][Full Text] [Related]
9. Temporal relationships between systemic lupus erythematosus and comorbidities.
Kuo CF; Chou IJ; Rees F; Grainge MJ; Lanyon P; Davenport G; Mallen CD; Chung TT; Chen JS; Zhang W; Doherty M
Rheumatology (Oxford); 2019 May; 58(5):840-848. PubMed ID: 30590795
[TBL] [Abstract][Full Text] [Related]
10. Mortality, causes of death and influence of medication use in patients with systemic lupus erythematosus vs matched controls.
Bultink IEM; de Vries F; van Vollenhoven RF; Lalmohamed A
Rheumatology (Oxford); 2021 Jan; 60(1):207-216. PubMed ID: 32653901
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964-95.
Björnådal L; Yin L; Granath F; Klareskog L; Ekbom A
J Rheumatol; 2004 Apr; 31(4):713-9. PubMed ID: 15088296
[TBL] [Abstract][Full Text] [Related]
12. Analysis of trends and causes of death in SLE patients over a 40-years period in a cohort of patients in the United Kingdom.
Lorenzo-Vizcaya A; Isenberg D
Lupus; 2021 Apr; 30(5):702-706. PubMed ID: 33472522
[TBL] [Abstract][Full Text] [Related]
13. Do Death Certificates Underestimate the Burden of Rare Diseases? The Example of Systemic Lupus Erythematosus Mortality, Sweden, 2001-2013.
Falasinnu T; Rossides M; Chaichian Y; Simard JF
Public Health Rep; 2018; 133(4):481-488. PubMed ID: 29928843
[TBL] [Abstract][Full Text] [Related]
14. Large-scale mortality gap between SLE and control population is associated with increased infection-related mortality in lupus.
Kedves M; Kósa F; Kunovszki P; Takács P; Szabó MZ; Karyekar C; Lofland JH; Nagy G
Rheumatology (Oxford); 2020 Nov; 59(11):3443-3451. PubMed ID: 32357240
[TBL] [Abstract][Full Text] [Related]
15. Malignancies among newly diagnosed systemic lupus erythematosus patients and their survival.
Kariniemi S; Rantalaiho V; Virta LJ; Kautiainen H; Puolakka K; Elfving P
Lupus; 2022 Dec; 31(14):1750-1758. PubMed ID: 36200539
[TBL] [Abstract][Full Text] [Related]
16. Incidence of systemic lupus erythematosus in Finland, 2000-2007, a nationwide study.
Elfving P; Puolakka K; Kautiainen H; Virta LJ; Pohjolainen T; Kaipiainen-Seppänen O
Clin Exp Rheumatol; 2014; 32(6):953-5. PubMed ID: 25328038
[TBL] [Abstract][Full Text] [Related]
17. New-onset non-infectious pulmonary manifestations among patients with systemic lupus erythematosus in Sweden.
Forbess LJ; Rossides M; Weisman MH; Simard JF
Arthritis Res Ther; 2019 Feb; 21(1):48. PubMed ID: 30728079
[TBL] [Abstract][Full Text] [Related]
18. Mortality profile related to systemic lupus erythematosus: a multiple cause-of-death analysis.
Souza DC; Santo AH; Sato EI
J Rheumatol; 2012 Mar; 39(3):496-503. PubMed ID: 22247362
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular event in systemic lupus erythematosus in northern Sweden: incidence and predictors in a 7-year follow-up study.
Bengtsson C; Ohman ML; Nived O; Rantapää Dahlqvist S
Lupus; 2012 Apr; 21(4):452-9. PubMed ID: 22065097
[TBL] [Abstract][Full Text] [Related]
20. Predictors of cardiovascular events in patients with systemic lupus erythematosus (SLE): a systematic review and meta-analysis.
Ballocca F; D'Ascenzo F; Moretti C; Omedè P; Cerrato E; Barbero U; Abbate A; Bertero MT; Zoccai GB; Gaita F
Eur J Prev Cardiol; 2015 Nov; 22(11):1435-41. PubMed ID: 25139772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
